The Fate and Fortunes of the Lazaurus Drug, Part One
Ampligen is all but unavailable in the United States, but a small group of Canadian patients are seeking to push their government toward approving the drug for what could be an exploding Canadian patient population. An inside look at the first meeting between of Hemispherx executives and Canadian activists to discuss strategy.
Q&A with Jose Montoya of Stanford about Cytokines, T cells, Journal Reviewers and NIH
Dr. Jose Montoya talks about the new cytokine paper linking severity of symtoms with inflammation in ME; the likelihood of a diagnostic test resulting from the study; how reviewers changed the paper; the NIH funding problem; and unpublished work on T cells that may aid or result in identification of an ME pathogen,